The effects of PPRHs were examined in an array of MYC-overexpressing and -addicted cell lines, including estrogen receptor-positive breast MCF-7, neuroblastoma SH-Sy5y, colorectal SW480, and prostate PC-3 cancer cells. Here, MYC is linked to cancer.